Search results for "Radionuclide"

showing 10 items of 196 documents

Post-Processing via Cation Exchange Cartridges: Versatile Options

2012

New 68Ge/68Ga radionuclide generators provide the positron emitter 68Ga (T½ = 67.7 min) as an easily available and relatively inexpensive source of a PET nuclide for labeling of interesting targeting vectors. However, currently available “ionic” 68Ge/68Ga radionuclide generators are not necessarily optimized for the routine synthesis of 68Ga-labeled radiopharmaceuticals in a clinical environment. Post-processing of 68Ge/68Ga generators using cation exchange resins provides chemically and radiochemically pure 68Ga with 97±2% within less than 4 min, with 68Ge almost completely removed, and ready for online labeling. This simple, fast, and efficient technology can be extended for new applicati…

chemistry.chemical_compoundCartridgechemistryRadiochemistrySynthonAcetonePositron emittersIonic bondingRadionuclide GeneratorIon-exchange resin
researchProduct

The Renaissance of the 68Ge/68Ga Radionuclide Generator Initiates New Developments in 68Ga Radiopharmaceutical Chemistry

2010

⁶⁸Ge/⁶⁸Ga radionuclide generators have been investigated for almost fifty years now, since the cyclotron-independent availability of positron emitting ⁶⁸Ga via the ⁶⁸Ge/⁶⁸Ga system had always attracted researches working in basic nuclear chemistry as well as radiopharmaceutical chemistry. However, it took decades and generations of research (and researchers) to finally approach a reliable level of ⁶⁸Ge/⁶⁸Ga generator designs, adequate to the modern requirements of radiometal labeling chemistry. ⁶⁸Ga radiopharmacy now is awaking from a sort of hibernation. The exciting perspective for the ⁶⁸Ge/⁶⁸Ga generator, now - more than ever, asks for systematic chemical, radiochemical, technological an…

chemistry.chemical_compoundGenerator (computer programming)chemistryDrug DiscoveryDOTAThe RenaissanceNanotechnologyGeneral MedicineRadionuclide GeneratorNuclear chemistryCurrent Topics in Medicinal Chemistry
researchProduct

Improved column-based radiochemical processing of the generator produced 68Ga.

2011

An improved chemical strategy for processing of the generator produced (68)Ga was developed based on processing of the original (68)Ge/(68)Ga generator eluate on a micro-column. Direct pre-concentration and purification of the eluted (68)Ga is performed on a cation-exchange resin in hydrochloric acid/acetone media. A supplementary step based on a second micro-column filled with a second resin allows direct re-adsorption of (68)Ga eluted from the cation exchanger. (68)Ga is finally striped from the second resin with a small volume of pure water. For this purpose a strong anion exchanger and a novel extraction chromatographic resin based on tetraalkyldiglycolamides are characterized. The stra…

chemistry.chemical_compoundRadiationChromatographyAqueous solutionGenerator (computer programming)chemistryIon exchangeElutionExtraction (chemistry)AcetoneHydrochloric acidRadionuclide GeneratorApplied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
researchProduct

Depth profiling of Pu, 241Am and 137Cs in soils from southern Belarus measured by ICP-MS and alpha- and gamma-spectrometry

2003

The depth distribution of plutonium, americium, and Cs-137 originating front the 1986 accident at the Chernobyl Nuclear Power Plant (NPP) was investigated in several soil profiles in the vicinity from Belarus. The vertical migration of transuranic elements in soils typical of the 30 km relocation area around Chernobyl NPP was studied using inductively coupled plasma mass spectrometry (ICP-MS), alpha spectrometry, and gamma spectrometry. Transuranic concentrations in upper soil layers ranged from 6 x 10(-12) g g(-1) to 6 x 10(-10) g g(-1) for plutonium and from 1.8 x 10(-13) g g(-1) to 1.6 x 10(-11) g g(-1) for americium. These concentrations correspond to specific activities of Pu239+240 of…

chemistry.chemical_elementCesiumAmericiumManagement Monitoring Policy and LawMass spectrometryMass SpectrometrySoil Pollutants RadioactiveInductively coupled plasma mass spectrometryRadionuclideAmericiumRadiochemistryPublic Health Environmental and Occupational HealthGeneral MedicinePlutoniumPlutoniumJTransuranic wastechemistryCesium RadioisotopesEnvironmental chemistrySoil waterSoil horizonddc:333.7Radioactive Hazard ReleaseUkraineEnvironmental MonitoringPower Plants
researchProduct

Maturation of a Key Resource – The Germanium-68/Gallium-68 Generator: Development and New Insights

2011

(68)Ge/(68)Ga radionuclide generators have been investigated for almost fifty years, since the cyclotron-independent availability of positron emitting (68)Ga via the (68)Ge/(68)Ga system had always attracted researches working in basic nuclear chemistry as well as radiopharmaceutical chemistry. However, it took decades and generations of research (and researchers) to finally reach a level of (68)Ge/(68)Ga radionuclide generator designs adequate to the modern requirements of radiometal labelling chemistry. Nevertheless, most of the existing commercial generator systems address aspects of (68)Ge breakthrough and safe synthesis of (68)Ga radiopharmaceuticals by adopting eluate post-processing …

chemistry.chemical_elementGallium RadioisotopesGermaniumNanotechnologyChemical FractionationRadiology Nuclear Medicine and imagingCation Exchange ResinsProcess engineeringAnion Exchange ResinsEdetic AcidChelating AgentsRadioisotopesPharmacologyGenerator (computer programming)Gallium-68 generatorGermaniumbusiness.industryRadionuclide GeneratorsSolid Phase ExtractionChemical fractionationRadioactivitychemistryPositron-Emission TomographyRadiopharmaceuticalsRadionuclide GeneratorbusinessCurrent Radiopharmaceuticals
researchProduct

Intrinsic backgrounds from Rn and Kr in the XENON100 experiment

2018

In this paper, we describe the XENON100 data analyses used to assess the target-intrinsic background sources radon ([InlineMediaObject not available: see fulltext.]), thoron ([InlineMediaObject not available: see fulltext.]) and krypton ([InlineMediaObject not available: see fulltext.]). We detail the event selections of high-energy alpha particles and decay-specific delayed coincidences. We derive distributions of the individual radionuclides inside the detector and quantify their abundances during the main three science runs of the experiment over a period of ∼4years, from January 2010 to January 2014. We compare our results to external measurements of radon emanation and krypton concentr…

data analysis methodPhysics - Instrumentation and DetectorsPhysics and Astronomy (miscellaneous)WIMPFOS: Physical scienceschemistry.chemical_elementlcsh:AstrophysicsRadonSciences de l'ingénieur01 natural sciencesIonNuclear physicsradon: nuclideXENONlcsh:QB460-4660103 physical scienceslcsh:Nuclear and particle physics. Atomic energy. Radioactivity[PHYS.PHYS.PHYS-INS-DET]Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det]010306 general physicsInstrumentation and Methods for Astrophysics (astro-ph.IM)[ PHYS.PHYS.PHYS-INS-DET ] Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det]Engineering (miscellaneous)nuclidebackground: radioactivitybackground: suppressionkryptonPhysicsRadionuclidePhysique010308 nuclear & particles physicsKryptonInstrumentation and Detectors (physics.ins-det)Alpha particleAstronomieDark Matter direct search experimentrespiratory tract diseasesRadon DaughtersBackgroundchemistrylcsh:QC770-798TPCAstrophysics - Instrumentation and Methods for Astrophysics
researchProduct

A no-carrier-added 72Se/72As radionuclide generator based on distillation

2004

Abstract Arsenic-72 is a positron emitting isotope with promising properties for syntheses of 72As-labelled radiopharmaceuticals for future application in positron emission tomography. This work describes the radiochemical separation of no-carrier-added 72Se from cyclotron irradiated germanium targets and the development of a 72Se/72As radionuclide generator, avoiding the addition of any selenium carrier. Using a vertical quartz tube device, no-carrier-added 72As is nearly quantitatively released from various chloride salt solutions containing 72Se within 10 min at a temperature of 100 °C in an HCl gas flow. The kinetics of the 72Se/72As isotope generator has been studied in relation to tem…

distillationSe-72IsotopeChemistryCyclotronRadiochemistrychemistry.chemical_elementGermaniumJlaw.inventionradionuclide generatorPositronlawddc:540As-72IrradiationPhysical and Theoretical ChemistryRadionuclide GeneratorDistillationSeleniumRadiochimica Acta
researchProduct

Analysis of radionuclide concentration in air released through the stack of a radiopharmaceutical production facility based on a medical cyclotron

2015

Abstract Positron emitting radionuclides are increasingly used in medical diagnostics and the number of radiopharmaceutical production facilities have been estimated to be growing worldwide. During the process of production and/or patient administration of radiopharmaceuticals, an amount of these radionuclides might become airborne and escape into the environment. Therefore, the analysis of radionuclide concentration in the air released to the stack is a very important issue to evaluate the dose to the population living around the plant. To this end, sampling and measurement of radionuclide concentration in air released through the stack of a Nuclear Medicine Center (NMC), provided with a c…

education.field_of_studyRadionuclideMedical diagnosticRadiationSettore ING-IND/20 - Misure E Strumentazione NucleariChemistrySystem of measurementNuclear engineeringPopulationDetectorCyclotronSampling (statistics)law.inventionStack (abstract data type)lawMedical cyclotron PET Radioactive air effluent RadiopharmaceuticalseducationSettore ING-IND/19 - Impianti NucleariNuclear chemistryRadiation Physics and Chemistry
researchProduct

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms

2021

Neuroendocrine neoplasms (NENs) are heterogeneous neoplasms which arise from neuroendocrine cells that are distributed widely throughout the body. Although heterogenous, many of them share their ability to overexpress somatostatin receptors (SSTR) on their cell surface. Due to this, SSTR and somatostatin have been a large subject of interest in the discovery of potential biomarkers and treatment options for the disease. The aim of this review is to describe the molecular characteristics of somatostatin and somatostatin receptors and its application in diagnosis and therapy on patients with NENs as well as the use in the near future of somatostatin antagonists.

endocrine systemQH301-705.5CellMedicine (miscellaneous)ReviewGeneral Biochemistry Genetics and Molecular BiologymedicineBiology (General)Tumorspeptide receptor radionuclide therapyReceptors d'hormonesneuroendocrine neoplasmssomatostatin analoguesSomatostatin receptorbusiness.industryTreatment optionsLU-DOTA-TATEmedicine.anatomical_structureSomatostatinPotential biomarkerssomatostatin receptorssomatostatin antagonistsCancer research68Ga PETbusinesshormones hormone substitutes and hormone antagonistsBiomedicines
researchProduct

Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results

2019

Abstract Background Preclinical biodistribution and dosimetric analysis of [177Lu]Lu-DOTAZOL suggest the bisphosphonate zoledronate as a promising new radiopharmaceutical for therapy of bone metastases. We evaluated biodistribution and normal organ absorbed doses resulting from therapeutic doses of [177Lu]Lu-DOTAZOL in patients with metastatic skeletal disease. Method Four patients with metastatic skeletal disease (age range, 64–83 years) secondary to metastatic castration-resistant prostate carcinoma or bronchial carcinoma were treated with a mean dose of 5968 ± 64 MBq (161.3 mCi) of [177Lu]Lu-DOTAZOL. Biodistribution was assessed with serial planar whole body scintigraphy at 20 min and 3,…

lcsh:Medical physics. Medical radiology. Nuclear medicine[177Lu]Lu-DOTAZOLBiodistributionKidneyUrinary bladderbusiness.industrymedicine.medical_treatmentlcsh:R895-920Organ absorbed dosesBone metastasisBisphosphonatemedicine.diseaseProstate carcinomamedicine.anatomical_structureAbsorbed doseRadionuclide therapymedicineRadiology Nuclear Medicine and imagingBone marrowBronchial carcinomabusinessNuclear medicineBone seeking therapeutic radionuclidesOriginal ResearchEJNMMI Research
researchProduct